Kindeva appoints David Stevens as new CEO
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
Stevens succeeds Milton Boyer, who has stepped down as CEO but will remain closely involved with the business as an independent member of Kindeva’s Board of Directors
India in the Changing Landscape of Life-Sciences Research & Development
Approval marks Venus Remedies’ first anti-infective marketing authorization in Indonesia and enables the country’s first generic entry for this critical antibiotic combination
The FDA also noted that current prescribing information for GLP-1 RAs already includes warnings about the risk of suicidal thoughts
Sabitha highlighted the growing relevance of minimally invasive therapies in modern medicine
DengiAll will be the first indigenous single-shot dengue vaccine in India and is expected to enter the markets by 2027
REDEMPLO is the first and only Health Canada-approved siRNA therapy for FCS
It is currently the only vaccine authorized by the Drug Controller General of India (DCGI) for active immunization against HEV in adults aged 18 to 65
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
Subscribe To Our Newsletter & Stay Updated